iShares Core High Dividend ETF vs Sana Biotechnology Inc — how do they compare? iShares Core High Dividend ETF trades at $28.19, while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: iShares Core High Dividend ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| HDV | SANA | |
|---|---|---|
52-Week High | $28.36 | $5.92 |
52-Week Low | $23.64 | $2.68 |
Market Cap | — | $873.84M |
Sector | — | Health |
Enterprise Value | — | $848.03M |
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →